Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PBSV

Pharma-Bio Serv, Inc.

USD

Set alert

Price alert · PBSV

All alert types
0.52 USD 0.00 0.00%
As of Oct 30, 2026
0.52 Day range 0.52
0.35 52-week range 0.60
YTD
-13.33%
1 year
-3.70%
Open
0.52
Prev close
0.52
Mkt cap
11.91M
Vol
1.00K
Avg vol
3.10K
EPS
0.01
P/E
52.00
More statistics
Low
0.52
High
0.52
Earnings
Feb 3, 2025

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for PBSV has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.19 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -123×
FY 2016: -85.6×FY 2017: -8.2×FY 2018: 19.0×FY 2019: 9.7×FY 2020: 14.5×FY 2021: -11.7×FY 2022: 19.6×FY 2023: 14.9×FY 2024: -17.1×FY 2025: -123×
FY 2016 5y median -11.7× FY 2025
P/S 1.4×
FY 2016: 1.1×FY 2017: 0.7×FY 2018: 1.4×FY 2019: 1.0×FY 2020: 1.4×FY 2021: 1.2×FY 2022: 1.0×FY 2023: 1.1×FY 2024: 1.4×FY 2025: 1.4×
FY 2016 5y median 1.2× FY 2025
P/B 1.0×
FY 2016: 1.0×FY 2017: 0.6×FY 2018: 1.2×FY 2019: 1.0×FY 2020: 1.3×FY 2021: 1.3×FY 2022: 1.2×FY 2023: 1.2×FY 2024: 1.0×FY 2025: 1.0×
FY 2016 5y median 1.2× FY 2025
P/FCF -55.9×
FY 2016: -19.9×FY 2017: -5.8×FY 2018: 6.7×FY 2019: -8.9×FY 2020: 20.2×FY 2021: 30.7×FY 2022: 34.5×FY 2023: 10.4×FY 2024: -18.3×FY 2025: -55.9×
FY 2016 5y median 10.4× FY 2025
EV/EBITDA 67.1×
FY 2016: 36.9×FY 2017: 0.2×FY 2018: 7.1×FY 2019: 2.0×FY 2020: 6.5×FY 2021: -2.0×FY 2022: 4.7×FY 2023: 7.2×FY 2024: -6.1×FY 2025: 67.1×
FY 2016 5y median 4.7× FY 2025
EV/Sales 1.0×
FY 2016: 0.4×FY 2017: -0.0×FY 2018: 0.5×FY 2019: 0.2×FY 2020: 0.7×FY 2021: 0.4×FY 2022: 0.3×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 1.0×
FY 2016 5y median 0.6× FY 2025
FCF Yield -1.8%
FY 2016: -5.0%FY 2017: -17.3%FY 2018: 14.8%FY 2019: -11.2%FY 2020: 5.0%FY 2021: 3.3%FY 2022: 2.9%FY 2023: 9.7%FY 2024: -5.5%FY 2025: -1.8%
FY 2016 5y median 2.9% FY 2025

Profitability

Gross Margin 32.3%
FY 2016: 29.6%FY 2017: 23.2%FY 2018: 32.0%FY 2019: 31.7%FY 2020: 30.9%FY 2021: 26.6%FY 2022: 25.2%FY 2023: 29.8%FY 2024: 26.5%FY 2025: 32.3%
FY 2016 5y median 26.6% FY 2025
Operating Margin -7.1%
FY 2016: -0.5%FY 2017: -9.1%FY 2018: 6.1%FY 2019: 8.7%FY 2020: 10.3%FY 2021: -19.2%FY 2022: 6.1%FY 2023: 6.6%FY 2024: -13.5%FY 2025: -7.1%
FY 2016 5y median -7.1% FY 2025
Net Margin -1.1%
FY 2016: -1.3%FY 2017: -9.1%FY 2018: 7.2%FY 2019: 10.7%FY 2020: 9.5%FY 2021: -10.4%FY 2022: 5.2%FY 2023: 7.7%FY 2024: -8.2%FY 2025: -1.1%
FY 2016 5y median -1.1% FY 2025
ROE -0.8%
FY 2016: -1.2%FY 2017: -6.8%FY 2018: 6.3%FY 2019: 10.1%FY 2020: 9.0%FY 2021: -11.0%FY 2022: 6.1%FY 2023: 8.1%FY 2024: -5.7%FY 2025: -0.8%
FY 2016 5y median -0.8% FY 2025
ROIC -5.3%
FY 2016: -0.4%FY 2017: -6.8%FY 2018: -3.9%FY 2019: 6.9%FY 2020: 7.2%FY 2021: -18.0%FY 2022: 5.3%FY 2023: 4.8%FY 2024: -8.8%FY 2025: -5.3%
FY 2016 5y median -5.3% FY 2025
ROA -0.7%
FY 2016: -1.1%FY 2017: -6.3%FY 2018: 5.0%FY 2019: 7.8%FY 2020: 6.9%FY 2021: -8.7%FY 2022: 4.9%FY 2023: 6.6%FY 2024: -4.8%FY 2025: -0.7%
FY 2016 5y median -0.7% FY 2025

Growth (YoY)

Revenue -5.3%
FY 2016: -16.5%FY 2017: -20.3%FY 2018: 14.2%FY 2019: 9.6%FY 2020: 10.5%FY 2021: -6.7%FY 2022: -3.6%FY 2023: -12.5%FY 2024: -44.0%FY 2025: -5.3%
FY 2016 FY 2025
Operating Income 50.5%
FY 2016: -105.2%FY 2017: -1453.1%FY 2018: 176.4%FY 2019: 55.9%FY 2020: 31.2%FY 2021: -273.2%FY 2022: 130.5%FY 2023: -4.9%FY 2024: -215.2%FY 2025: 50.5%
FY 2016 FY 2025
EPS (diluted) 87.0%
FY 2016: -116.0%FY 2017: -452.3%FY 2018: 190.4%FY 2019: 63.0%FY 2020: -1.4%FY 2021: -201.9%FY 2022: 148.2%FY 2023: 30.4%FY 2024: -159.5%FY 2025: 87.0%
FY 2016 FY 2025
Free Cash Flow 69.5%
FY 2016: -3733.8%FY 2017: -82.0%FY 2018: 279.8%FY 2019: -163.0%FY 2020: 164.9%FY 2021: -46.0%FY 2022: -27.8%FY 2023: 228.6%FY 2024: -138.6%FY 2025: 69.5%
FY 2016 FY 2025

Financial Health

Current Ratio 7.7×
FY 2016: 10.0×FY 2017: 12.7×FY 2018: 9.1×FY 2019: 7.1×FY 2020: 7.5×FY 2021: 8.6×FY 2022: 9.5×FY 2023: 9.0×FY 2024: 8.3×FY 2025: 7.7×
FY 2016 5y median 8.6× FY 2025
Quick Ratio 7.7×
FY 2016: 10.0×FY 2017: 12.7×FY 2018: 9.1×FY 2019: 7.1×FY 2020: 7.5×FY 2021: 8.6×FY 2022: 9.5×FY 2023: 9.0×FY 2024: 8.3×FY 2025: 7.7×
FY 2016 5y median 8.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -24.9×
FY 2016: -62.1×FY 2017: 16.4×FY 2018: -13.7×FY 2019: -6.6×FY 2020: -6.0×FY 2021: 4.5×FY 2022: -11.4×FY 2023: -7.7×FY 2024: 5.9×FY 2025: -24.9×
FY 2016 5y median -7.7× FY 2025
Interest Coverage 0.0×
FY 2016: -0.4×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 13.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 7.1%FY 2019: 0.0%FY 2020: 5.8%FY 2021: 7.1%FY 2022: 17.4%FY 2023: 8.8%FY 2024: 12.9%FY 2025: 13.9%
FY 2016 5y median 12.9% FY 2025
Payout Ratio -1712.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 135.1%FY 2019: 0.0%FY 2020: 84.1%FY 2021: -82.7%FY 2022: 342.4%FY 2023: 131.6%FY 2024: -221.5%FY 2025: -1712.0%
FY 2016 5y median -82.7% FY 2025

Annual · latest fiscal year ends 2025-10-31